Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes

European Journal of Clinical Pharmacology
G FaccioláG Tybring

Abstract

The present study was carried out to identify the cytochrome P450 enzyme(s) involved in the 6-hydroxylation and O-demethylation of melatonin. The formation kinetics of 6-hydroxymelatonin and N-acetylserotonin were determined using human liver microsomes and cDNA yeast-expressed human enzymes (CYP1A2, 2C9 and 2C19) over the substrate concentration range 1-1000 microM. Selective inhibitors and substrates of various cytochrome P450 enzymes were also employed. Fluvoxamine was a potent inhibitor of 6-hydroxymelatonin formation, giving 50 +/- 5% and 69 +/- 9% inhibition at concentrations of 1 microM and 10 microM, respectively, after incubation with 50 microM melatonin. Furafylline, sulphaphenazole and omeprazole used at low and high concentrations substantially inhibited both metabolic pathways. cDNA yeast-expressed CYP1A2, CYP2C9 and CYP2C19 catalysed the formation of the two metabolites, confirming the data obtained with specific inhibitors and substrates. Our results strongly suggest that 6-hydroxylation, the main metabolic pathway of melatonin, is mediated mainly, but not exclusively, by CYP1A2, the high-affinity enzyme involved in melatonin metabolism, confirming the observation that a single oral dose of fluvoxamine increases ...Continue Reading

Citations

Jul 12, 2008·Archives of Toxicology·Olavi PelkonenHannu Raunio
Apr 13, 2005·European Journal of Clinical Pharmacology·Carina UrsingSven Röjdmark
Apr 6, 2006·Cancer Causes & Control : CCC·Christian Bartsch, Hella Bartsch
Jun 24, 2008·Journal of Toxicology and Environmental Health. Part a·Brunhilde BlomekeHermann C Roemer
Jun 21, 2001·Biochemical and Biophysical Research Communications·L F OlsenM Allegra
Jan 25, 2013·Gastroenterology Research and Practice·Cezary ChojnackiJan Chojnacki
Jan 1, 2014·Antioxidants·Daniel P CardinaliLuis I Brusco
May 31, 2002·Journal of Endocrinological Investigation·C UrsingS Röjdmark
Apr 22, 2014·Journal of Pharmaceutical and Biomedical Analysis·Dany SpaggiariSerge Rudaz
Apr 27, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tae-Kang KimAndrzej T Slominski
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Nov 26, 2015·Expert Opinion on Drug Metabolism & Toxicology·Carolina Céspedes-GarroAdrián LLerena
Feb 27, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N J ProctorA Rostami-Hodjegan
Mar 15, 2003·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D F V LewisP S Goldfarb
Aug 29, 2006·British Journal of Clinical Pharmacology·Janne T BackmanPertti J Neuvonen
Oct 17, 2006·Basic & Clinical Pharmacology & Toxicology·Sebastian HärtterKari Laine
Jan 5, 2011·International Journal of Alzheimer's Disease·Venkatramanujam SrinivasanDaniel P Cardinali
Mar 7, 2012·Hormones and Behavior·Daniel P CardinaliPablo Scacchi
Jul 17, 2009·Pharmacological Reports : PR·Jolanta B ZawilskaJosephine Arendt
Apr 16, 2014·Physiology & Behavior·Eleni PapagiannidouCostas Ioannides
Mar 8, 2013·International Journal of Molecular Sciences·Yu-Chieh ChenLi-Tung Huang
Feb 1, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cezary ChojnackiTomasz Popławski
Nov 18, 2003·British Journal of Clinical Pharmacology·Sebastian HärtterKari Laine
Aug 4, 2018·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Lisa A Ostrin
Jan 29, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrzej SlominskiDesmond J Tobin
Jan 15, 2009·Journal of Clinical Psychopharmacology·Armando L MoreraAlfonso Garcia-Hernandez
Nov 19, 2009·Journal of Pineal Research·Thomas K H ChangEugene Y H Yeung
Jan 8, 2008·Alimentary Pharmacology & Therapeutics·P A H M WijnenG H Koek
Oct 30, 2003·The Pharmacogenomics Journal·A LLerenaA De La Rubia
Apr 6, 2019·Journal of Basic and Clinical Physiology and Pharmacology·Johnson Segun ShowandeTitilayo Oyelola Fakeye
Dec 12, 2007·Journal of Clinical Pharmacology·Sophia L MarkantonisArgyro Fassoulaki
Oct 29, 2004·Drug Metabolism and Drug Interactions·David F V LewisMaurice Dickins
Nov 30, 2012·Journal of Gastroenterology and Hepatology·Cezary ChojnackiJan Chojnacki
Jun 25, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Masashi MiseSetsuko Komuro
May 21, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shu-Ying ChangA David Rodrigues
Oct 18, 2003·The Journal of Pharmacology and Experimental Therapeutics·Takanori AkagiShigehiro Ohdo
Jan 28, 2015·The Journal of Biological Chemistry·Hemantkumar ChavanPartha Krishnamurthy
Nov 27, 2004·Pharmacogenetics·Masashi MiseToshihiko Fujii
Jul 10, 2020·Toxicology and Industrial Health·Wale Johnson AdeyemiLuqman Aribidesi Olayaki
Oct 21, 2016·Clinical Pharmacokinetics·Gail D Anderson, Lingtak-Neander Chan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.